CoChat

miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression

Open access
Chakravarthi, Balabhadrapatruni V.S.K., Chandrashekar, Darshan S., Agarwal, Sumit, Balasubramanya, Sai Akshaya Hodigere, Pathi, Satya S., Goswami, Moloy T., Jing, Xiaojun, Wang, Rui, Mehra, Rohit, Asangani, Irfan A., Chinnaiyan, Arul M., Manne, Upender, Sonpavde, Guru, Netto, George J., Gordetsky, Jennifer, Varambally, Sooryanarayana · 2018 · Molecular Cancer Research
Cited by 59

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

In aggressive prostate cancers, the oncoprotein STMN1 (also known as stathmin 1 and oncoprotein 18) is often overexpressed. STMN1 is involved in various cellular processes, including cell proliferation, motility, and tumor metastasis. Here, it was found that the expression of STMN1 RNA and protein is elevated in metastatic prostate cancers. Knockdown of STMN1 resulted in reduced proliferation and invasion of cells and tumor growth and metastasis in vivo. Furthermore, miR-34a downregulated STMN1 by directly binding to its 3′-UTR. Overexpression of miR-34a in prostate cancer cells reduced proliferation and colony formation, suggesting that it is a tumor suppressor. The transcriptional corepressor C-terminal binding protein 1 (CtBP1) negatively regulated expression of miR-34a. Furthermore, gene expression profiling of STMN1-modulated prostate cancer cells revealed molecular alterations, including elevated expression of growth differentiation factor 15 (GDF15), which is involved in cancer progression and potentially in STMN1-mediated oncogenesis. Thus, in prostate cancer, CtBP1-regulated miR-34a modulates STMN1 expression and is involved in cancer progression through the CtBP1\miR-34a\STMN1\GDF15 axis. Implications: The CtBP1\miR-34a\STMN1\GDF15 axis is a potential therapeutic target for treatment of aggressive prostate cancer. Mol Cancer Res; 16(7); 1125–37. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1541-7786.mcr-17-0230

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 59

Metadata

Authors
Chakravarthi, B. V. S. K., Chandrashekar, D. S., Agarwal, S., Balasubramanya, S. A. H., Pathi, S. S., Goswami, M. T., Jing, X., Wang, R., Mehra, R., Asangani, I. A., Chinnaiyan, A. M., Manne, U., Sonpavde, G., Netto, G. J., Gordetsky, J., & Varambally, S.
Venue
Molecular Cancer Research
Published
2018-07-01
Volume
16
Issue
7
Pages
1125-1137
ISSN
  • 1541-7786 (ISSN-L)
  • 1557-3125
OpenAlex
W2762769581
Cited by
59
References
7
FWCI
1.39
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-17-0230
The paper
Chakravarthi, B. V. S. K., Chandrashekar, D. S., Agarwal, S., Balasubramanya, S. A. H., Pathi, S. S., Goswami, M. T., Jing, X., Wang, R., Mehra, R., Asangani, I. A., Chinnaiyan, A. M., Manne, U., Sonpavde, G., Netto, G. J., Gordetsky, J., & Varambally, S. (2018). miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-17-0230

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.